“Genetically modifying a patient’s white blood cells turns them into potent cancer killers, UK researchers have revealed.”

The researchers isolated T-lymphocyte cells from cancer patients and genetically modified these cells to carry a gene that produces an antibody that recognizes a specific molecule in the cancer cells.

“This antibody allows the T-cell to bind onto the cancer cell and trigger a chain of events that turns the T-cells into ‘killer cells’.”